Pharmacy Chain 36.6 (MOEX:APTK)
Russia · Delayed Price · Currency is RUB 12.50
-0.00 (-0.03%)
At close: Jul 8, 2022
Pharmacy Chain 36.6 Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 105,614 | 87,163 | 67,358 | 59,048 | 44,104 | |
Revenue Growth (YoY) | 21.17% | 29.40% | 14.07% | 33.88% | 12.32% |
Cost of Revenue | 71,073 | 59,027 | 45,319 | 39,049 | 29,147 |
Gross Profit | 34,541 | 28,136 | 22,039 | 19,999 | 14,957 |
Selling, General & Admin | 24,834 | 21,658 | 17,825 | 15,931 | 14,235 |
Other Operating Expenses | -278 | -270 | -298 | -444 | -456 |
Operating Expenses | 24,575 | 21,418 | 17,586 | 15,681 | 13,997 |
Operating Income | 9,966 | 6,718 | 4,453 | 4,318 | 960 |
Interest Expense | -8,877 | -6,578 | -4,140 | -4,241 | -3,239 |
Interest & Investment Income | 179 | 346 | 283 | 391 | 412 |
Currency Exchange Gain (Loss) | 47 | 9 | -45 | 14 | 30 |
Other Non Operating Income (Expenses) | -795 | -308 | -251 | -251 | -212 |
EBT Excluding Unusual Items | 520 | 187 | 300 | 231 | -2,049 |
Gain (Loss) on Sale of Assets | -5 | -190 | -28 | 107 | -2 |
Asset Writedown | -24 | 212 | -110 | 73 | 609 |
Pretax Income | 491 | 209 | 162 | 411 | -1,442 |
Income Tax Expense | 228 | -58 | 42 | 188 | -492 |
Earnings From Continuing Operations | 263 | 267 | 120 | 223 | -950 |
Net Income to Company | 263 | 267 | 120 | 223 | -950 |
Net Income | 263 | 267 | 120 | 223 | -950 |
Net Income to Common | 263 | 267 | 120 | 223 | -950 |
Net Income Growth | -1.50% | 122.50% | -46.19% | - | - |
Shares Outstanding (Basic) | 7,509 | 7,576 | 7,617 | 7,630 | 7,630 |
Shares Outstanding (Diluted) | 7,509 | 7,576 | 7,617 | 7,630 | 7,630 |
Shares Change (YoY) | -0.89% | -0.54% | -0.17% | - | 12.11% |
EPS (Basic) | 0.04 | 0.04 | 0.02 | 0.03 | -0.12 |
EPS (Diluted) | 0.04 | 0.04 | 0.02 | 0.03 | -0.12 |
EPS Growth | -0.61% | 123.72% | -46.10% | - | - |
Free Cash Flow | 4,076 | 5,771 | 6,399 | 5,901 | 2,528 |
Free Cash Flow Per Share | 0.54 | 0.76 | 0.84 | 0.77 | 0.33 |
Gross Margin | 32.70% | 32.28% | 32.72% | 33.87% | 33.91% |
Operating Margin | 9.44% | 7.71% | 6.61% | 7.31% | 2.18% |
Profit Margin | 0.25% | 0.31% | 0.18% | 0.38% | -2.15% |
Free Cash Flow Margin | 3.86% | 6.62% | 9.50% | 9.99% | 5.73% |
EBITDA | 11,429 | 8,142 | 5,848 | 5,724 | 2,130 |
EBITDA Margin | 10.82% | 9.34% | 8.68% | 9.69% | 4.83% |
D&A For EBITDA | 1,463 | 1,424 | 1,395 | 1,406 | 1,170 |
EBIT | 9,966 | 6,718 | 4,453 | 4,318 | 960 |
EBIT Margin | 9.44% | 7.71% | 6.61% | 7.31% | 2.18% |
Effective Tax Rate | 46.44% | - | 25.93% | 45.74% | - |
Advertising Expenses | 512 | 441 | 543 | 368 | 213 |